Immediate Impact
28 standout
Citing Papers
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
2024 Standout
Works of Mitul Gandhi being referenced
Phase 3 randomized study of loncastuximab tesirine plus rituximab versus immunochemotherapy in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): LOTIS-5.
2021
Impact of oncogene rearrangement patterns on outcomes in patients with double‐hit non‐Hodgkin lymphoma
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mitul Gandhi | 121 | 126 | 75 | 27 | 181 | |
| Claudia Mannu | 111 | 147 | 66 | 19 | 206 | |
| George Kanellis | 67 | 119 | 79 | 18 | 206 | |
| Allison Winter | 109 | 95 | 65 | 37 | 205 | |
| Yazeed Sawalha | 86 | 91 | 50 | 40 | 154 | |
| Cristina Becchimanzi | 110 | 165 | 69 | 19 | 228 | |
| Gaetana Capobianco | 132 | 194 | 86 | 21 | 274 | |
| Mahsa Khanlari | 106 | 87 | 61 | 28 | 181 | |
| Elsa Poullot | 82 | 124 | 49 | 26 | 217 | |
| Laura Cereceda | 123 | 191 | 80 | 18 | 255 | |
| Pablo Mozas | 134 | 208 | 121 | 35 | 266 |
All Works
Loading papers...